Neurology

Decoding the Data: Diagnostic Testing and Your Lab Reports

At a Glance

For a child with sudden movement episodes, a normal MRI or EEG does not rule out a genetic disorder. Comparing blood and spinal-fluid glucose, checking spinal-fluid lactate, recording an event with video-EEG, and using broad genetic testing can help doctors identify the cause.

Navigating the diagnostic process for paroxysmal movement disorders can be confusing, especially when many standard tests—like brain scans and electrical brain monitoring—come back “normal.” This does not mean nothing is wrong; rather, these tests may be normal in genetic movement disorders, though normal results do not prove the cause or rule out every alternative ^[1]^[2].

The Role of MRI and EEG: Rule-Out Tools

In most children with these genetic conditions, the Brain MRI and EEG (electroencephalogram) are unremarkable ^[1]. This is actually a critical finding because it helps your doctor evaluate other conditions that can look similar, such as:

Structural Lesions: Such as tumors, vascular (blood vessel) malformations, or injuries to the basal ganglia ^[3]^[4].
Inflammation: Such as Multiple Sclerosis (MS) or encephalitis, which would typically show up as bright spots or “lesions” on an MRI ^[3]^[5].
Typical Epilepsy: While movement disorders can look like seizures, an EEG helps assess the electrical activity. An interictal (between-attack) EEG can be normal in epilepsy, so a normal result does not definitively rule out a seizure, especially if no typical event was captured ^[6]^[7].

The Lumbar Puncture: Checking the Brain’s Fuel

If your doctor suspects Glut1 Deficiency Syndrome (the SLC2A1 gene), a Lumbar Puncture (spinal tap) may be discussed to measure the level of glucose (sugar) in the Cerebrospinal Fluid (CSF) that surrounds the brain ^[8].

For the results to be accurate, the doctor must perform a paired sample, meaning they draw blood at the same time they collect the CSF. They are looking for a specific marker called the CSF:Blood Glucose Ratio ^[9].

Normal Ratio: Usually above 0.60.
Glut1 Indicator: A lower ratio (such as 0.45 or lower) supports the diagnosis, but reference ranges vary with age and testing methods, and a normal value does not absolutely exclude it ^[9]^[10]. Note: Never impose a fast on a child before a pediatric procedure without explicit medical instructions, as fasting can worsen symptoms.
Lactate: Doctors also look at CSF Lactate. In Glut1 deficiency, this is often low or at the low end of normal, whereas in other metabolic conditions (like mitochondrial diseases), it might be high ^[11]^[12].

Why “Broad” Genetic Testing is Best

In the past, doctors tested one gene at a time. However, because genes like PRRT2, SLC2A1, and CACNA1A can all cause very similar symptoms, “single-gene” testing often leads to missed diagnoses ^[13]^[14].

Today, the preferred approach is Next-Generation Sequencing (NGS), such as a Movement Disorder Panel or Whole Exome Sequencing (WES) ^[2]^[13]. This allows the lab to look at hundreds of genes simultaneously. This is especially important for children who have “overlapping” symptoms—like a mix of movement attacks, persistent balance issues (ataxia), and muscle stiffness (spasticity) ^[15]^[16].

Possible Tests to Discuss

To ensure your child has had a thorough evaluation, you can use this checklist to discuss next steps with your neurologist:

[ ] Paired Glucose Test: Was CSF glucose measured at the same time as blood glucose, and is it clinically indicated?
[ ] CSF Lactate: Was this checked to help evaluate metabolic issues?
[ ] Genetic Panel or WES: Does the genetic test cover genes like PRRT2, SLC2A1, PNKD, CACNA1A, KCNA1, ADCY5, or ATP1A3?
[ ] Deletion/Duplication Analysis: Sometimes a gene isn’t “misspelled” but is missing a large chunk; a standard sequence might miss this ^[14].
[ ] Video-EEG: If there is any doubt about whether the attacks are seizures, was a video-EEG performed to capture an actual event? ^[17]
[ ] Metabolic Screening: Were blood tests for lactate, ammonia, and amino acids performed to look for other energy-processing issues? ^[18]
[ ] Genetic Counseling: Have we discussed the implications of testing, including a Variant of Uncertain Significance (VUS) or penetrance?

Common questions in this guide

Can a normal MRI or EEG rule out a genetic movement disorder?

No. Brain MRI and EEG are often normal in genetic movement disorders, and a normal EEG between attacks does not fully exclude epilepsy if a typical event was not recorded. These tests are useful for looking for other causes, such as structural brain changes or inflammation.

What does the CSF-to-blood glucose ratio mean in Glut1 deficiency?

Doctors compare glucose in spinal fluid, or CSF, with a blood glucose sample taken at the same time. A ratio above about 0.60 is usually considered normal, while a ratio around 0.45 or lower supports Glut1 deficiency, although cutoffs vary by age and testing method. A normal ratio does not completely rule out the condition.

Why might my child need a broad genetic panel or whole-exome sequencing?

Several genes, including PRRT2, SLC2A1, and CACNA1A, can cause similar movement episodes, balance problems, or stiffness. A broad panel or whole-exome sequencing examines many genes at once and may reduce the chance of missing the genetic cause. The clinician can explain what the test includes and how uncertain results are handled.

What can CSF lactate tell doctors?

CSF lactate is one part of the evaluation of how the brain is using energy. It is often low or low-normal in Glut1 deficiency, while a high level may suggest other metabolic conditions, including some mitochondrial disorders. The result must be interpreted with the symptoms and other test findings.

Why would a video-EEG be useful for movement attacks?

A video-EEG records the child's behavior and brain electrical activity during an actual spell. This can help doctors determine whether an episode is more consistent with a seizure or a movement disorder. A routine EEG that does not capture a typical event may not answer that question.

What genetic tests may be needed if the first SLC2A1 test is negative?

The next step depends on the CSF glucose result, symptoms, and the type of testing already performed. Doctors may consider deletion and duplication analysis, broader testing, or specialized evaluation for changes outside the usual gene sequence or in only some cells. Genetic counseling can help explain the limitations and possible uncertain results.

Should my child fast before a lumbar puncture?

Only if the treating team specifically instructs you to do so. Fasting can worsen symptoms in some children, so do not impose a fast before the procedure without medical guidance. Follow the pediatric team's instructions about food, drink, and medications.

Get notified when new evidence is published on Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (18)

1
Genetic Links to Episodic Movement Disorders: Current Insights.
Garg D, Mohammad S, Shukla A, Sharma S
The application of clinical genetics 2023; (16()):11-30 doi:10.2147/TACG.S363485.
PMID: 36883047
2
Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.
Garone G, Capuano A, Travaglini L, et al.
International journal of molecular sciences 2020; (21(10)) doi:10.3390/ijms21103603.
PMID: 32443735
3
Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical-radiological features and treatment. Case report of seven patients.
Ciampi E, Uribe-San-Martín R, Godoy-Santín J, et al.
Multiple sclerosis (Houndmills, Basingstoke, England) 2017; (23(13)):1791-1795 doi:10.1177/1352458517702968.
PMID: 28397579
4
Kinesigenic dyskinesias after ENT surgery misdiagnosed as focal epilepsy.
Trapp SD, Noachtar S, Kaufmann E
BMJ case reports 2022; (15(3)) doi:10.1136/bcr-2021-247760.
PMID: 35351750
5
Is faciobrachial dystonic seizure a misnomer? A case report of atypical leg-predominant tonic-dystonic attacks in LGI1-associated encephalitis.
Faouzi M, Galati A, Kaza S, Bruno MK
BMC neurology 2026; (26(1)).
PMID: 42216157
6
[Diagnosis of non-epileptic paroxysmal disorders and epileptic seizures].
Noachtar S, Güldiken B
Der Nervenarzt 2017; (88(10)):1109-1118 doi:10.1007/s00115-017-0397-9.
PMID: 28842725
7
Non-epileptic paroxysmal events at pediatric video-electroencephalography monitoring unit over a 15-year period.
Yavuz P, Gunbey C, Karahan S, et al.
Seizure 2023; (108()):89-95 doi:10.1016/j.seizure.2023.04.016.
PMID: 37119582
8
Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group.
Klepper J, Akman C, Armeno M, et al.
Epilepsia open 2020; (5(3)):354-365 doi:10.1002/epi4.12414.
PMID: 32913944
9
The diagnostic and prognostic role of cerebrospinal fluid biomarkers in glucose transporter 1 deficiency: a systematic review.
Mastrangelo M, Manti F, Ricciardi G, et al.
European journal of pediatrics 2024; (183(9)):3665-3678 doi:10.1007/s00431-024-05657-6.
PMID: 38954008
10
[Clinical characteristics and ketogenic diet therapy of glucose transporter type 1 deficiency syndrome in children: a multicenter clinical study].
Yu LF, Zhang YQ, Duan J, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2020; (58(11)):881-886 doi:10.3760/cma.j.cn112140-20200822-00819.
PMID: 33120458
11
Novel cerebrospinal fluid biomarkers of glucose transporter type 1 deficiency syndrome: Implications beyond the brain's energy deficit.
Peters TMA, Merx J, Kooijman PC, et al.
Journal of inherited metabolic disease 2023; (46(1)):66-75 doi:10.1002/jimd.12554.
PMID: 36088537
12
A Novel SUCLA2 Mutation Presenting as a Complex Childhood Movement Disorder.
Garone C, Gurgel-Giannetti J, Sanna-Cherchi S, et al.
Journal of child neurology 2017; (32(2)):246-250 doi:10.1177/0883073816666221.
PMID: 27651038
13
Genetic updates on paroxysmal dyskinesias.
Liao JY, Salles PA, Shuaib UA, Fernandez HH
Journal of neural transmission (Vienna, Austria : 1996) 2021; (128(4)):447-471 doi:10.1007/s00702-021-02335-x.
PMID: 33929620
14
Paroxysmal Movement Disorders.
Harvey S, King MD, Gorman KM
Frontiers in neurology 2021; (12()):659064 doi:10.3389/fneur.2021.659064.
PMID: 34177764
15
Complicated paroxysmal kinesigenic dyskinesia associated with SACS mutations.
Lu Q, Shang L, Tian WT, et al.
Annals of translational medicine 2020; (8(1)):8 doi:10.21037/atm.2019.11.31.
PMID: 32055599
16
High Genetic Diagnostic Yield for Patients with Rare Movement Disorders at a Single-Center Neurogenetics Clinic.
Penn D, Amir Y, David GB, et al.
Movement disorders clinical practice 2025; (12(11)):1811-1820 doi:10.1002/mdc3.70145.
PMID: 40470849
17
[A case of a pathological variant of the PRRT2 gene in twins with paroxysmal kinesiogenic dyskinesia].
Ermolenko NA, Krasnorutskaya ON, Bykova VA, et al.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2023; (123(9. Vyp. 2)):83-86 doi:10.17116/jnevro202312309283.
PMID: 37942977
18
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes.
Castellotti B, Ragona F, Freri E, et al.
Journal of neurology 2019; (266(6)):1439-1448 doi:10.1007/s00415-019-09280-6.
PMID: 30895386

This page explains diagnostic testing for children with paroxysmal movement symptoms for informational purposes only and does not replace medical advice. A pediatric neurologist or other qualified clinician should interpret your child's results and recommend next steps.